• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . The burden and dynamics of hospital-acquired SARS-CoV-2 in England

tetano

Editor, Senior Moderator
Nature


. 2023 Oct 18.
doi: 10.1038/s41586-023-06634-z. Online ahead of print. The burden and dynamics of hospital-acquired SARS-CoV-2 in England

Ben S Cooper[SUP] 1 2 [/SUP], Stephanie Evans[SUP] 3 [/SUP], Yalda Jafari[SUP] 4 [/SUP], Thi Mui Pham[SUP] 5 [/SUP], Yin Mo[SUP] 6 7 8 9 [/SUP], Cherry Lim[SUP] 6 7 [/SUP], Mark G Pritchard[SUP] 6 10 [/SUP], Diane Pople[SUP] 3 [/SUP], Victoria Hall[SUP] 3 [/SUP], James Stimson[SUP] 3 [/SUP], David W Eyre[SUP] 11 12 13 14 [/SUP], Jonathan M Read[SUP] 15 [/SUP], Christl A Donnelly[SUP] 10 16 17 [/SUP], Peter Horby[SUP] 10 [/SUP], Conall Watson[SUP] 10 [/SUP], Sebastian Funk[SUP] 4 [/SUP], Julie V Robotham[SUP] #[/SUP][SUP] 3 14 [/SUP], Gwenan M Knight[SUP] #[/SUP][SUP] 4 18 [/SUP]



Affiliations
Abstract

Hospital-based transmission had a dominant role in Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) epidemics[SUP]1,2[/SUP], but large-scale studies of its role in the SARS-CoV-2 pandemic are lacking. Such transmission risks spreading the virus to the most vulnerable individuals and can have wider-scale impacts through hospital-community interactions. Using data from acute hospitals in England, we quantify within-hospital transmission, evaluate likely pathways of spread and factors associated with heightened transmission risk, and explore the wider dynamical consequences. We estimate that between June 2020 and March 2021 between 95,000 and 167,000 inpatients acquired SARS-CoV-2 in hospitals (1% to 2% of all hospital admissions in this period). Analysis of time series data provided evidence that patients who themselves acquired SARS-CoV-2 infection in hospital were the main sources of transmission to other patients. Increased transmission to inpatients was associated with hospitals having fewer single rooms and lower heated volume per bed. Moreover, we show that reducing hospital transmission could substantially enhance the efficiency of punctuated lockdown measures in suppressing community transmission. These findings reveal the previously unrecognized scale of hospital transmission, have direct implications for targeting of hospital control measures and highlight the need to design hospitals better equipped to limit the transmission of future high-consequence pathogens.


 
Back
Top Bottom